Log In
BCIQ
Print this Print this
 

PF-03882845, PF-3882845

  Manage Alerts
Collapse Summary General Information
Company Pfizer Inc.
DescriptionNot disclosed
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationDiabetic nephropathy
Indication DetailsTreat diabetic nephropathy (DN)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today